Skip to main content

Table 2 Laboratory analysis

From: Comparison of the red blood cell indices based on accuracy, sensitivity, and specificity to predict one-year mortality in heart failure patients

Laboratory Parameters

All patients a (n = 400)

Survivors b (n = 323, 81%)

Deceased b (n = 77, 19%)

p-value c

Troponin I (Mic gr/L)

0.1 (0.1–0.1)

0.1 (0.1–0.1)

0.1 (0.1–0.1)

0.092

WBC count (10^3/µL)

7.4 (6–9)

7.3 (6–9)

8 (6–10)

0.142

RBC count (10^6/ µL)

4.4 (3.8–4.8)

4.4 (4–4.8)

3.9 (3.5–4.8)

0.004

Hemoglobin (g/dL)

12.0 (10.7–13.5)

12.5 (10.9–13.7)

11.2 (9.5–12.4)

p < 0.001

Hematocrit (%)

36 (32–40)

37 (33–40)

33 (30–37)

P < 0.001

MCV (f lit)

84 (78–89)

85 (78–89)

83 (78–87)

0.098

MCH (Pg)

28 (25–29)

28 (25–30)

27 (25–28)

0.003

MCHC (g/dL)

33 (32–34)

33 (32–34)

32 (31–33)

0.018

RDW-CV (fL)

14 (13–16)

14 (13–16)

16 (14–17)

P < 0.001

Platelet count (10^3/µL)

187 (155–231)

186 (155–231)

200 (152–235)

0.425

PT(sec)

13.8 (13–16)

13.7 (13–15)

14.8 (13–17)

0.161

PTT (sec)

33 (30–38)

33 (30–38)

34 (30–39)

0.244

INR (Index)

1.2 (1–1.5)

1.2 (1–1.4)

1.3 (1.1–1.7)

0.183

Random BS (mg/dL)

120 (96–173)

120 (95–170)

118 (101–183)

0.305

Sodium (mEq/dL)

139 (136–141)

139 (137–141)

137 (133–140)

0.347

Potassium (mEq/dL)

4.3 (4–4.6)

4.2 (4–4.6)

4.4 (4–5)

0.465

BUN (mg/dL)

21 (16–28)

20 (16–27)

21 (16–35)

0.121

Creatinine (mg/dL)

1.1 (0.9–1.4)

1.1 (0.9–1.3)

1.2 (1–1.4)

0.051

SGOT (mg/dL)*

22 (17–35) [150]

22 (17–32)

31 (18–57)

0.081

SGPT (IU/L)*

22 (14–38) [150]

20 (14–35)

29 (17–84)

0.064

ALP (mg/dL)*

188 (153–251) [144]

182 (150–248)

194 (176–270)

0.074

Albumin (mg/dL)*

3.9 (3.6–4.2) [134]

4 (3.7–4.2)

3.6 (3.3–4)

0.128

Globulin (g/dL)*

2.4 (2.1–2.9) [108]

2.4 (2.1–2.8)

2.9 (2.3–3.2)

0.506

Total protein (g/dL)*

6.5 (6-6.8) [108]

6.5 (6.1–6.8)

6.5 (5.8–6.8)

0.709

Total bilirubin (mg/dL)*

0.9 (0.5–1.3) [115]

0.8 (0.5–1.3)

1.15 (0.7–2.2)

0.075

Direct bilirubin (mg/dL)*

0.3 (0.2–0.5) [119]

0.3 (0.2–0.4)

0.5 (0.3–0.7)

0.064

Triglyceride (mg/dL)*

98 (71–121) [163]

100 (73–124)

84 (66–100)

0.053

Cholesterol (mg/dL)*

135 (104–164) [162]

138 (116–161)

109 (90–167)

0.145

HDL-CH (mg/dL)*

37 (30–43) [156]

38 (32–43)

36 (23–45)

0.293

LDL-C (mg/dL)*

74 (49–98) [156]

76 (50–98)

54 (48–95)

0.204

Uric acid (mg/dL)*

7.8 (5.6–9.5) [109]

7.0 (5.3–8.7)

9.8 (8.3–12.2)

P < 0.001

Ck-mb (IU/L)*

14 (11–20) [130]

13 (10–17)

17 (12–29)

0.152

  1. WBC White blood cell ; RBC Red blood cells; MCV Mean corpuscular volume; MCH Mean corpuscular hemoglobin; MCHC Mean corpuscular hemoglobin concentration; RDW Red blood cell distribution width; PT Prothrombin time; PTT Partial thrombin time; INR international normalized ratio; BS Blood sugar; BUN Blood urea nitrogen; SGOT Serum glutamic oxaloacetic transaminase; SGPT Serum glutamic pyruvic transaminase; ALP Alkaline phosphatase; HDL High-density lipoprotein; LDL Low-density lipoprotein; CK-MB Creatine kinase-MB
  2. a Laboratory parameters were represented by Median (first quartile-third quartile)
  3. b Comparing the groups of patients was tested using the Mann–Whitney U test or the Student’s t-test depending on the distribution normality of the variables, and illustrated by Median (first quartile-third quartile)
  4. c All statistically significant p values (p < 0.05) are in bold
  5. * Shows laboratory parameters that were not requested for all patients. The number of patients from which statistics was calculated is shown in a bracket in front of the quartiles
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us